Artialis is a biotechnology company offering Preclinical, Clinical, and Biotesting services aiming to accelerate the development of ATMP, drugs, medical devices, and food supplements. Artialis is specialized in Musculoskeletal, inflammatory, gastrointestinal, nutrition, and age-related disorders.
Preclinical: We deliver Pharmacodynamics, Pharmacokinetics, Toxicity, Biocompatibility, Local tolerance, and Proof-Of Concept studies (in vivo models) as well as in vitro studies or R&D testing to deliver characterization and MOA data.
Clinical: Full clinical services, ISO compliant, on Medical devices, food supplements, drugs, ATMP from Phase 1 to Phase 4 post-market studies and Veterinarian clinical studies. We propose a tailor-made design with gold standards and innovative parameters (soluble markers, imaging, and pain/mobility).
Biotesting: Sample measurement of more than 50 validated biomarkers for preclinical or clinical research using colorimetric immunoassays (ELISA) and multiplex MSD technology. We also propose OMICs analyses.